Alfasigma has agreed to purchase Nordic Group, a move aimed at strengthening its speciality care business and expanding its reach in Europe, Canada, and Japan.
The transaction is structured through a share purchase agreement with SEVER Life Sciences for 100% of Nordic Group and its subsidiaries.
While specific financial terms have not been disclosed, the deal is subject to customary conditions, including relevant regulatory clearances.
It will bring Nordic Pharma’s rheumatoid arthritis business, led by the Nordimet methotrexate franchise, into Alfasigma’s rheumatology portfolio.
This portfolio currently includes Jyseleca, approved for second-line treatment in inflammatory and autoimmune diseases such as rheumatoid arthritis and ulcerative colitis, and marketed by Alfasigma in the EU, EEA, and UK.
In addition, the acquisition covers Nordic Pharma’s products in women’s health, critical care, and ophthalmology.
Following the deal, Alfasigma will operate directly in 18 European countries, and extend its commercial activities to Canada and Japan.
The addition of Nordic Pharma will see approximately 265 new employees join Alfasigma.
Alfasigma CEO Francesco Balestrieri said: “Alfasigma is pursuing a deliberate strategy to identify the right opportunities to build our global specialty and rare disease business, focused on areas of significant unmet need in gastroenterology and immunology.
“The acquisition of Nordic Pharma marks a decisive step forward in that journey, strengthening our European presence and expanding our rheumatology portfolio. By combining our portfolios, scientific expertise and talented teams, we are better positioned to deliver meaningful innovation and value for patients and shareholders.”
Nordic Group CEO Charlotte Phelps said: “Alfasigma is the right partner for Nordic Pharma as we enter our next phase of growth. Both companies are patient-focused, rooted in science and entrepreneurial. We look forward to combining our experience to support patients.”
Alfasigma is a privately owned pharmaceutical company headquartered in Italy, distributing products in more than 100 markets and employing around 4,000 people.
